Clinical Trials Logo

Filter by:
NCT ID: NCT02865005 Completed - Acne Vulgaris Clinical Trials

Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris

Start date: February 2016
Phase: Phase 3
Study type: Interventional

Multi-center, double-blind, randomized, placebo-controlled trial of Dapsone 5.0% Gel in the treatment of acne vulgaris.

NCT ID: NCT02651220 Completed - Acne Clinical Trials

Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris

Start date: November 2015
Phase: Phase 3
Study type: Interventional

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multiple-Site Clinical Study to Evaluate the Therapeutic Equivalence and Safety of adapalene and benzoyl peroxide gel, 0.3%/2.5% (Actavis Laboratories UT, Inc.) to Epiduo® Forte (adapalene and benzoyl peroxide) gel 0.3%/2.5% (Galderma) in the treatment of Acne Vulgaris

NCT ID: NCT02563054 Completed - Gastric Cancer Clinical Trials

A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer

Start date: April 2003
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy and safety of oral capecitabine (Xeloda) versus 5-fluorouracil (5-FU), in combination with intravenous (IV) cisplatin, in participants with advanced and/or metastatic gastric cancer. The anticipated time on study treatment is at least 6 weeks and continued up to disease progression, and the target sample size is 300 individuals.

NCT ID: NCT02267746 Completed - Acne Vulgaris Clinical Trials

A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulgaris

Start date: June 2014
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the safety and therapeutic equivalence of a generic tazarotene foam 0.1% and the reference listed Fabior™ (tazarotene foam, 0.1%) in the treatment of acne vulgaris.

NCT ID: NCT01885156 Completed - Tinea Cruris Clinical Trials

Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris

Start date: August 2013
Phase: Phase 3
Study type: Interventional

To see how well Naftin 1% cream works when applied once daily to the affected area. The results will be compared to those using a placebo cream, which is a cream with no active ingredient. Safety will also be measured.

NCT ID: NCT01501799 Completed - Acne Vulgaris Clinical Trials

A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne Vulgaris

Start date: July 2011
Phase: N/A
Study type: Interventional

EPIDUO™ (adapalene and benzoyl peroxide) Gel 0.1%/2.5%, marketed by GALDERMA LABORATORIES, L.P., is a safe and effective topical therapy used for the treatment of acne vulgaris. Actavis Mid-Atlantic LLC has developed a generic formulation of adapalene and benzoyl peroxide topical gel 0.1%/2.5%,and the current study is designed to evaluate the safety and efficacy of this formulation to determine if it is bioequivalent to EPIDUO™.

NCT ID: NCT01396811 Completed - Tinea Pedis Clinical Trials

Topical Antifungal Treatment for Tinea Pedis

Start date: July 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if a topical antifungal cream is safe and effective for the treatment of tinea pedis.

NCT ID: NCT01349998 Completed - Tinea Pedis Clinical Trials

Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis

Start date: May 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to examine the long-term safety of treating recurrent episodes of tinea pedis for 14 days for each recurrence and recurrent episodes of tinea corporis or tinea cruris for 7 days for each recurrence with Product 33525.

NCT ID: NCT01342315 Completed - Tinea Cruris Clinical Trials

Topical Antifungal Treatment for Tinea Cruris

Start date: May 2011
Phase: Phase 3
Study type: Interventional

To determine if a topical antifungal cream is safe and effective for the treatment of tinea cruris

NCT ID: NCT01182636 Completed - Acne Vulgaris Clinical Trials

Bioequivalence of Adapalene Topical Gel in Patients With Acne Vulgaris

Start date: July 2007
Phase: Phase 1
Study type: Interventional

The objective of this study was to evaluate the efficacy and safety of the test formulation of adapalene gel 0.1% (PLIVA Research & Development Ltd.) as compared to the already marketed formulation, Differin® (adapalene 0.1%) topical gel (Galderma Laboratories) in patients with acne vulgaris.